REGENXBIO, Inc. (RGNX)
8.06
-2.66
(-24.81%)
USD |
NASDAQ |
Aug 24, 16:00
8.08
+0.02
(+0.25%)
After-Hours: 20:00
REGENXBIO Price to Book Value : 6.083 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.091 |
| August 20, 2026 | 8.347 |
| August 19, 2026 | 9.072 |
| August 18, 2026 | 8.355 |
| August 17, 2026 | 8.551 |
| August 14, 2026 | 8.125 |
| August 13, 2026 | 8.046 |
| August 12, 2026 | 8.234 |
| August 11, 2026 | 8.038 |
| August 10, 2026 | 7.864 |
| August 07, 2026 | 8.091 |
| August 06, 2026 | 8.514 |
| August 05, 2026 | 7.925 |
| August 04, 2026 | 7.774 |
| August 03, 2026 | 7.517 |
| July 31, 2026 | 7.313 |
| July 30, 2026 | 7.638 |
| July 29, 2026 | 7.261 |
| July 28, 2026 | 7.246 |
| July 27, 2026 | 7.328 |
| July 24, 2026 | 7.344 |
| July 23, 2026 | 7.736 |
| July 22, 2026 | 7.698 |
| July 21, 2026 | 7.804 |
| July 20, 2026 | 7.789 |
| Date | Value |
|---|---|
| July 17, 2026 | 7.464 |
| July 16, 2026 | 8.453 |
| July 15, 2026 | 9.261 |
| July 14, 2026 | 9.276 |
| July 13, 2026 | 9.623 |
| July 10, 2026 | 10.53 |
| July 09, 2026 | 11.81 |
| July 08, 2026 | 11.49 |
| July 07, 2026 | 11.34 |
| July 06, 2026 | 11.19 |
| July 02, 2026 | 10.02 |
| July 01, 2026 | 9.880 |
| June 30, 2026 | 9.042 |
| June 29, 2026 | 28.96 |
| June 26, 2026 | 25.66 |
| June 25, 2026 | 25.07 |
| June 24, 2026 | 24.41 |
| June 23, 2026 | 24.36 |
| June 22, 2026 | 22.21 |
| June 18, 2026 | 19.10 |
| June 17, 2026 | 19.34 |
| June 16, 2026 | 16.97 |
| June 15, 2026 | 17.31 |
| June 12, 2026 | 16.31 |
| June 11, 2026 | 15.38 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Capricor Therapeutics, Inc. | 1.607 |
| Biogen, Inc. | 1.709 |
| Ardelyx, Inc. | 6.245 |
| Ocugen, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 2.412 |
| PEG Ratio | -0.2301 |
| Price | 8.06 |
| Earnings Yield | -46.96% |
| Market Cap | 436.56M |
| PEGY Ratio | -0.2301 |